(1)Espen Enerly a Ph.D researcher at the Cancer Registry of Norway in his research article titled “An observational study comparing HPV prevalence and type distribution between HPV-vaccinated and -unvaccinated girls after introduction of school-based HPV vaccination in Norway”(2019) says that there is a lower prevalence of vaccine-targeted HPV types in vaccinated girls from the first birth cohort eligible for school-based HPV vaccination in Norway. (2) Enerly provides evidence that vaccines eradicate HPV by testing 312 young women in Norway who both have and have not recently received the vaccine. (3) The purpose of this article is to determine the efficiency of HPV vaccines in order to prove that they are safe and should be given on a large scale. (4) Enerly establishes an audience with normal people wondering how effective vaccines are, and with scholars within the field of biology.
